These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8221803)
1. R56865, an antiarrhythmic drug with class III effects that terminates ouabain induced ventricular tachycardia in an inverse rate dependent manner. Vos MA; van Deursen RT; Gorgels AP; Leunissen JD; Wellens HJ Cardiovasc Res; 1993 Aug; 27(8):1491-7. PubMed ID: 8221803 [TBL] [Abstract][Full Text] [Related]
2. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity. Damiano BP; Stump GL; Yagel SK J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842 [TBL] [Abstract][Full Text] [Related]
3. The protective action of R56865 against ouabain-induced intoxication in rat heart isolated atria and ventricles. Finet M; Bravo G; Godfraind T Eur J Pharmacol; 1989 May; 164(3):555-63. PubMed ID: 2767125 [TBL] [Abstract][Full Text] [Related]
4. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias. Wu KM; Proakis AG; Hunter TL; Shanklin JR Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512 [TBL] [Abstract][Full Text] [Related]
5. Mechanism-specific antiarrhythmic effects of the potassium channel activator levcromakalim against repolarization-dependent tachycardias. Vos MA; Gorgels AP; Lipcsei GC; De Groot SH; Leunissen JD; Wellens HJ J Cardiovasc Electrophysiol; 1994 Sep; 5(9):731-42. PubMed ID: 7827712 [TBL] [Abstract][Full Text] [Related]
6. R56865, a potent new antiarrhythmic agent, effective during ischemia and reperfusion in the rat heart. Garner JA; Hearse DJ; Bernier M J Cardiovasc Pharmacol; 1990 Sep; 16(3):468-79. PubMed ID: 1700220 [TBL] [Abstract][Full Text] [Related]
7. Effects of magnesium and ethmozin on ventricular tachycardia induced by ouabain and ventricular pacing in conscious dogs with complete atrioventricular block. Fazekas T; Vos MA; Leunissen JD; Wellens HJ Acta Physiol Hung; 1993; 81(1):59-70. PubMed ID: 8178656 [TBL] [Abstract][Full Text] [Related]
8. R56865 is antifibrillatory in reperfused ischemic guinea-pig hearts, even when given only during reperfusion. Scheufler E; Mozes A; Guttmann I; Wilffert B Cardiovasc Drugs Ther; 1995 Aug; 9(4):545-53. PubMed ID: 8547204 [TBL] [Abstract][Full Text] [Related]
9. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog. Remme WJ; Verdouw PD; Hagemeyer F Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591 [TBL] [Abstract][Full Text] [Related]
11. Effect of R56865 on cardiac sarcoplasmic reticulum function and its role as an antagonist of digoxin at the sarcoplasmic reticulum calcium release channel. McGarry SJ; Scheufler E; Williams AJ Br J Pharmacol; 1995 Jan; 114(1):231-7. PubMed ID: 7712023 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of quinetholate, lidocaine and procainamide on ouabain-induced ventricular tachycardia and cardiac function. Taylor SE; Nash CB Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):279-90. PubMed ID: 677962 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Na+/Ca2+ overload with R 56,865 protects against cardiac arrhythmias elicited by ouabain in vivo in guinea-pigs. Lu HR; Remeysen P; De Clerck F Eur J Pharmacol; 1993 Apr; 235(1):89-93. PubMed ID: 8519283 [TBL] [Abstract][Full Text] [Related]
14. Conversion of ouabain-induced ventricular tachycardia in dogs with epicardial lidocaine: pharmacodynamics and functional effects. Sintov A; Scott WA; Gallagher KP; Levy RJ Pharm Res; 1990 Jan; 7(1):28-33. PubMed ID: 2300532 [TBL] [Abstract][Full Text] [Related]
15. The protective effects of CP-060S on ischaemia- and reperfusion- induced arrhythmias in anaesthetized rats. Koga T; Fukazawa M; Suzuki Y; Akima M; Adachi Y; Tamura K; Kato T; Kuromaru O Br J Pharmacol; 1998 Apr; 123(7):1409-17. PubMed ID: 9579737 [TBL] [Abstract][Full Text] [Related]